Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients. J. Can. Res. Updates [Internet]. 2025 Aug. 15 [cited 2026 May 6];14:114-20. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/854